Once the project was ready, I fed the entire codebase into NotebookLM. I uploaded all the .py files as plain text files, ...

Dec. 8 (UPI) --The U.S. Food and Drug Administration on Monday announced the approval of the first hematopoietic stem cell transplant therapy to treat patients with rare but severe aplastic anemia.

Trevor Ault learned he was a match for a stranger with bone cancer. After watching his colleague, "Good Morning America" co-anchor Robin Roberts, raise awareness about stem cell donation after ...

NEW DELHI, Nov 21 (Reuters) - India's federal government said on Friday it was implementing four new labour codes, overhauling outdated rules governing factories and workers for decades. Labour codes ...

Korean biotechnology company, Nature Cell, is planning to open a stem cell facility in Baltimore, bringing 500 new jobs, the governor announced Tuesday. The 100,000 square foot manufacturing facility ...

A study published in the Proceedings of the National Academy of Sciences has uncovered new clues to why some therapeutic proteins are so difficult to manufacture. The work—led by Nathan Lewis, PhD, ...

In public schools across the country, states are implementing "bell-to-bell" cell phone bans—policies that restrict smartphone use among students throughout the entire school day. As of this fall, 30 ...

A controversial text message poll was sent to Tallahassee residents regarding Tallahassee Memorial Hospital. The poll was sent by Grow Tallahassee, a pro-business group supporting a hospital ...

This is read by an automated voice. Please report any issues or inconsistencies here. David Ball of Soft Cell, whose delectably sleazy synth-pop arrangement drove that English duo’s 1981 hit “Tainted ...

Dave Ball, the multi-instrumentalist, producer, and songwriter who performed alongside Marc Almond in the influential synth-pop duo Soft Cell, died yesterday (October 22). The band’s publicist, Debbie ...

Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.

Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...